1. Market Research
  2. > All Companies
  3. > SkyePharma Plc (SKP) - Financial and Strategic SWOT Analysis Review

SkyePharma Plc (SKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SkyePharma PLC (SkyePharma) develops, manufactures and markets prescription oral and inhalation pharmaceutical products. The company licenses cover 16 approved inhalation, oral, topical and injectable products. The company offers products catering to the treatment of asthma, depression, Parkinson’s disease, lipid disorders, hypertension, pain/inflammation, rheumatoid arthritis, angina, BPH (urinary symptoms), actinic keratosis, and pain management. Its products are developed based on its proprietary technologies, Geomatrix and Geoclock for controlled release pharmaceutical products; and SkyeProtect, SkyeDry and SkyeStable, among others for inhalation formulations. It manages a research and development facility in Muttenz, Switzerland; and a production center in Lyon, France. The company operates along with its subsidiaries in Switzerland, France, Jersey and the US. SkyePharma is headquartered in London, the UK.

SkyePharma Plc Key Recent Developments

Mar 24, 2015: Preliminary announcement of 2014 annual results
Oct 10, 2013: SkyePharma Announces Interim Management Statement
Oct 10, 2013: Skyepharma Publishes Interim Management Statement
Aug 22, 2013: Skyepharma appoints Andrew Derodra as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

SkyePharma Plc (SKP) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures5
Section 1 - About the Company 6
SkyePharma Plc - Key Facts 6
SkyePharma Plc - Key Employees 7
SkyePharma Plc - Key Employee Biographies 8
SkyePharma Plc - Major Products and Services 9
SkyePharma Plc - Medical Equipment Pipeline Products Data 10
SkyePharma Plc Pipeline Products by Equipment Type 10
SkyePharma Plc Pipeline Products by Development Stage 12
SkyePharma Plc - Pharmaceutical Pipeline Products Data 14
SkyePharma Plc, Pipeline Products by Therapy Area 14
SkyePharma Plc, Pipeline Products by Development Phase 15
SkyePharma Plc - History 18
SkyePharma Plc - Company Statement 20
SkyePharma Plc - Locations And Subsidiaries 21
Head Office 21
Other Locations and Subsidiaries 21
SkyePharma Plc - Key Manufacturing Facilities 22
Section 2 - Company Analysis 23
SkyePharma Plc - Business Description 23
SkyePharma Plc - Corporate Strategy 24
SkyePharma Plc - SWOT Analysis 25
SWOT Analysis - Overview 25
SkyePharma Plc - Strengths 25
Strength - Proprietary Technologies 25
Strength - Geographical Diversity 25
Strength - Strategic Partnerships 25
SkyePharma Plc - Weaknesses 26
Weakness - Declining Operational Performance 26
SkyePharma Plc - Opportunities 27
Opportunity - Strategic Acquisitions 27
Opportunity - Market Potential: Respiratory Devices 27
SkyePharma Plc - Threats 28
Threat - Competitive Atmosphere 28
Threat - Stringent Government Regulations 28
Threat - Technological Advancements 28
SkyePharma Plc - Key Competitors 29
Section 3 - Company Financial Ratios 30
Financial Ratios - Capital Market Ratios 30
Financial Ratios - Annual Ratios 31
Performance Chart 32
Financial Performance 32
Financial Ratios - Interim Ratios 33
Financial Ratios - Ratio Charts 34
Section 4 - Company's Lifesciences Financial Deals and Alliances 35
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 35
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 36
SkyePharma Plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 37
SkyePharma Plc, Medical Equipment, Deals By Type, 2009 to YTD 2015 38
SkyePharma Plc, Recent Deals Summary 39
Section 5 - Company's Recent Developments 40
Mar 24, 2015: Preliminary announcement of 2014 annual results 40
Oct 09, 2014: Skyepharma Announces Interim Management Statement 41
Aug 21, 2014: Skyepharma Reports Interim Results Statement 43
Aug 21, 2014: Skyepharma announces Interim Results 2014 44
Mar 31, 2014: Skyepharma Announces Its Annual Results For The Year Ended 31 December 2013 45
Mar 05, 2014: Skyepharma Announces Board Changes 47
Feb 28, 2014: Skyepharma - Board Change - Senior Independent Non-Executive Director 48
Section 6 - Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
SkyePharma Plc, Key Facts 6
SkyePharma Plc, Key Employees 7
SkyePharma Plc, Key Employee Biographies 8
SkyePharma Plc, Major Products and Services 9
SkyePharma Plc Number of Pipeline Products by Equipment Type 10
SkyePharma Plc Pipeline Products by Equipment Type 11
SkyePharma Plc Number of Pipeline Products by Development Stage 12
SkyePharma Plc Pipeline Products by Development Stage 13
SkyePharma Plc, Number of Pipeline Products by Therapy Area 14
SkyePharma Plc, Number of Pipeline Products by Development Stage 15
SkyePharma Plc, Pipeline Products By Therapy Area and Development Phase 16
SkyePharma Plc, History 18
SkyePharma Plc, Subsidiaries 21
SkyePharma Plc, Key Manufacturing Facilities 22
SkyePharma Plc, Key Competitors 29
SkyePharma Plc, Ratios based on current share price 30
SkyePharma Plc, Annual Ratios 31
SkyePharma Plc, Interim Ratios 33
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 35
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 36
SkyePharma Plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 37
SkyePharma Plc, Medical Equipment, Deals By Type, 2009 to YTD 2015 38
SkyePharma Plc, Recent Deals Summary 39
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List of Figures
SkyePharma Plc Pipeline Products by Equipment Type 10
SkyePharma Plc Pipeline Products by Development Stage 12
SkyePharma Plc, Pipeline Products by Therapy Area 14
SkyePharma Plc, Pipeline Products by Development Phase 15
SkyePharma Plc, Performance Chart (2010 - 2014) 32
SkyePharma Plc, Ratio Charts 34
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 35
SkyePharma Plc, Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 36
SkyePharma Plc, Medical Equipment, Deals By Year, 2009 to YTD 2015 37
SkyePharma Plc, Medical Equipment, Deals by Type, 2009 to YTD 2015 38

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.